Melanoma immunotherapy using mature DCs expressing the constitutive proteasome
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2013-06-24 / J. Clin. Invest. 2013 Jul;123(7):3135-45Active immunotherapy using dendritic cells in the treatment of glioblastoma multiforme
/in Dendritic Cells, Glioblastoma, International Publications /von 2013-06-21 / Cancer Treat. Rev. 2013 Dec;39(8):891-907Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics
/in International Publications, Micronutrients /von 2013-06-19 / Antioxid. Redox Signal. 2013 Dec;19(17):2141-56A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2013-06-18 / J Transl Med 2013 Jun;11:149Biochemical and immunologic markers in patients with metastatic melanoma treated with chemotherapy and dendritic cell vaccine.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2013-06-04 / J Clin Oncol 31, 2013 (suppl; abstr e20042)Immune response, clinical outcome and safety of dendritic cell vaccine in combination with cytokine-induced killer cell therapy in cancer patients
/in Dendritic Cells, International Publications /von 2013-06-04 / Oncol Lett 2013 Aug;6(2):537-541Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 3040)Role of mesenchymal stem cells in delivering Newcastle disease virus to glioma cells and glioma stem cells and enhancing the oncolytic effect of the virus by secreting TRAIL.
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 3100)Survival in metastatic Ewing sarcoma (EWS) and rhabdomyosarcoma (RMS) following consolidation immunotherapy with autologous lymphocyte infusion, dendritic cell vaccines ± CYT107 (rhIL-7).
/in Dendritic Cells, Hypernephroma, International Publications, Soft Tissue Sarcoma /von 2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 10013)
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution